PMID: 15232328Jul 3, 2004Paper

Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial

Journal of Clinical Psychopharmacology
J G RabkinShu Hsing Lin

Abstract

While testosterone's ameliorative effects on depressive disorders and fatigue in HIV-positive patients have been suggested in the literature, no placebo-controlled trial selecting for depressive disorders and including a standard antidepressant has been conducted. Accordingly, this double-blind trial was designed to determine whether testosterone, as well as fluoxetine, is superior to placebo for depression, fatigue, or both. One hundred twenty-three men with HIV/AIDS with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorder entered the 8-week trial and were randomized to testosterone (up to 400 mg IM testosterone cypionate biweekly), fluoxetine (up to 60 mg/d), or double placebo. Outcome variables were the Clinical Global Impressions Scale for mood and for fatigue, the Hamilton Rating Scale for Depression, and the Chalder Fatigue Scale. Ninety men completed the trial. In intention-to-treat analyses, mood response rates were 54%, 47%, and 44% for fluoxetine, testosterone, and placebo, respectively. Among completers, mood response rates were 70%, 57%, and 53%, respectively; in neither analysis were differences between treatments statistically significant. In contrast, testosterone was super...Continue Reading

References

Mar 1, 1988·The American Journal of Medicine·A S DobsB F Polk
Aug 1, 1988·Archives of General Psychiatry·J B Williams
Jan 1, 1993·Journal of Psychosomatic Research·T ChalderE P Wallace
Jul 21, 1998·Journal of Affective Disorders·S N Seidman, J G Rabkin
Feb 6, 1999·Journal of Clinical Psychopharmacology·J G RabkinR Rabkin
Dec 6, 2000·Journal of Clinical Psychopharmacology·D S Robinson, K Rickels
Mar 7, 2002·Archives of General Psychiatry·Donald F KleinAlexander Bystritsky
Apr 10, 2002·JAMA : the Journal of the American Medical Association·B Timothy WalshMadelyn Gould
Dec 31, 2002·The American Journal of Psychiatry·Harrison G PopeJames I Hudson
Jan 14, 2003·The Journal of Clinical Psychiatry·Paul J PerryTimothy L Holman

❮ Previous
Next ❯

Citations

Jun 1, 2006·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Rakhi KohliHenry S Sacks
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Shalender BhasinJames T Dalton
Aug 12, 2005·International Journal of Impotence Research·A Seftel
Aug 4, 2011·Psychology, Health & Medicine·Lorraine SherrJose Catalan
Nov 15, 2005·AIDS·Sanjay BasuR Douglas Bruce
Jul 22, 2009·Journal of Strength and Conditioning Research·Jay R HoffmanAlan D Rogol
May 25, 2010·The Journal of Clinical Psychiatry·Judith G RabkinPatrick J McGrath
Sep 12, 2006·Primary Care Companion to the Journal of Clinical Psychiatry·Tiziano ColibazziWilliam S Gilmer
Mar 2, 2011·The British Journal of Psychiatry : the Journal of Mental Science·David TaylorUNKNOWN pharmacology subgroup of the National Institute for Health and Clinical Excellence Guideline Development Group for Depressi
Dec 18, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ursula ReichenpfaderBradley N Gaynes
May 31, 2012·Journal of Neurovirology·Crystal C Watkins, Glenn J Treisman
Mar 21, 2006·Issues in Mental Health Nursing·Demetrius James Porche, Danny G Willis
Feb 2, 2008·International Review of Psychiatry·Stephen J Ferrando, Zachary Freyberg
May 12, 2006·The Journal of the Association of Nurses in AIDS Care : JANAC·Joachim G VossWilliam Holzemer
Sep 23, 2016·PloS One·Samantha HuoAdriane Fugh-Berman
Sep 23, 2009·Hormones and Behavior·Gen KanayamaHarrison G Pope
Jun 4, 2008·Psychosomatic Medicine·Martin J Repetto, John M Petitto
Jan 23, 2018·The Cochrane Database of Systematic Reviews·Ingrid Eshun-WilsonJohn A Joska
Oct 20, 2005·The Cochrane Database of Systematic Reviews·K JohnsR C Corrin
Jan 28, 2014·Korean journal of urology·Jane AshbyHossein Sadeghi-Nejad
Jul 25, 2009·Journal of Psychiatric Practice·Fahd Aziz ZarroufMartin Kommor
Apr 24, 2008·American Journal of Physiology. Endocrinology and Metabolism·Philip E KnappShalender Bhasin
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Lauren RaynerMatthew Hotopf
Jul 15, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Crystal C WatkinsGlenn J Treisman
Jul 11, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Diana Ying WuSonya Shin
May 31, 2015·The Cochrane Database of Systematic Reviews·Martin MückeLukas Radbruch
Jan 15, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Dionna W WilliamsLeah H Rubin
Mar 3, 2017·Indian Journal of Psychological Medicine·Pranjali P MendheMinakshi N Parikh
Sep 22, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Nathalie T Shamlian, Martin G Cole
May 28, 2020·The American Journal of Psychiatry·Jennifer B DwyerUNKNOWN APA Council of Research Task Force on Novel Biomarkers and Treatments

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.